GLI1 inhibitor GANT61 exhibits antitumor efficacy in T-cell lymphoma cells through down-regulation of p-STAT3 and SOCS3.
about
Targeting the PI3K/AKT pathway via GLI1 inhibition enhanced the drug sensitivity of acute myeloid leukemia cells.TFDP3 confers chemoresistance in minimal residual disease within childhood T-cell acute lymphoblastic leukemia.Role of GLI Transcription Factors in Pathogenesis and Their Potential as New Therapeutic Targets
P2860
GLI1 inhibitor GANT61 exhibits antitumor efficacy in T-cell lymphoma cells through down-regulation of p-STAT3 and SOCS3.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
GLI1 inhibitor GANT61 exhibits ...... gulation of p-STAT3 and SOCS3.
@en
type
label
GLI1 inhibitor GANT61 exhibits ...... gulation of p-STAT3 and SOCS3.
@en
prefLabel
GLI1 inhibitor GANT61 exhibits ...... gulation of p-STAT3 and SOCS3.
@en
P2093
P2860
P356
P1433
P1476
GLI1 inhibitor GANT61 exhibits ...... gulation of p-STAT3 and SOCS3.
@en
P2093
Lingyun Geng
Xiangxiang Zhou
P2860
P304
48701-48710
P356
10.18632/ONCOTARGET.9792
P407
P577
2016-06-02T00:00:00Z